Company Overview - CARBIOS is a biotech company focused on developing and industrializing biological solutions to reinvent the life cycle of plastics and textiles, aiming to reduce pollution and promote a circular economy [4]. - The company has two main technologies: biorecycling of PET and biodegradation of PLA, both of which are reaching industrial and commercial scales [4]. - CARBIOS has been recognized scientifically, including features in prestigious publications like Nature, and collaborates with major brands in various industries to enhance product recyclability [4]. Liquidity Contract and Financial Performance - As of June 30, 2025, CARBIOS reported assets on its liquidity account as part of a contract with Natixis ODDO BHF [2][3]. - The liquidity contract is in accordance with the French Financial Market Authority's regulations established in June 2021 [3]. - For the first half of 2025, the company executed 2,381 buy transactions totaling €2,121,620.77 for 324,721 shares, while sell transactions totaled €2,170,808.76 for 330,062 shares [5][11]. Future Developments - Construction of the world's first industrial biorecycling plant is expected to restart in the second half of 2025, contingent on securing additional funding [4]. - The biorecycling demonstration plant has been operational since 2021, showcasing CARBIOS's commitment to advancing its technologies [4].
Report on Carbios’ liquidity contract with Natixis ODDO BHF
Globenewswire·2025-07-08 16:00